Konnektia Technologies LLC

PhenoVista Biosciences LLC is a San Diego-based company specializing in high-content imaging and the development of relevant cell models, offering both off-the-shelf and custom assay services for the drug discovery process. Their expertise spans a range of research areas including fibrosis, neurobiology, oncology, immuno-oncology, and cell gene therapy. As a trusted discovery partner, PhenoVista focuses on delivering innovative solutions through customized services such as Ready-2-Go assays and advanced imaging analysis. The company is committed to supporting researchers and scientists in their quest for new therapeutic approaches. Generated from the website

Eclipse Bioinnovations Inc is a San Diego-based company specializing in RNA genomics technologies and solutions for accelerating RNA research and therapeutics development. Their comprehensive platform covers a wide range of RNA mechanisms, including RBP target transcripts, miRNA-mRNA interactions, siRNA-mRNA interactions, m6A modifications, ribosome profiling, RNA secondary structure, and transcript ends. With a focus on end-to-end coverage, Eclipse Bioinnovations offers services such as RBP-eCLIP, miR-eCLIP, m6A-eCLIP, eRibo Pro, eSHAPE, 5 End-Seq, and 3 End-Seq, providing valuable insights and discoveries for researchers and drug developers. Known for their robust and high-quality data, Eclipse Bioinnovations has garnered praise from customers in the scientific community. Their RNA genomics technologies have been instrumental in target assessment processes, enabling strategic decisions in RNA-targeting drug development. Researchers have also commended Eclipse Bioinnovations for their approachable and supportive staff, making experiments and projects more accessible. With their expertise in RNA genomics and commitment to accelerating RNA discovery, Eclipse Bioinnovations is a trusted partner for researchers worldwide.Generated from the website

Chemical Diversity Labs, based in San Diego, California, is a leader in the drug discovery industry with over 32 years of experience collaborating with pharmaceutical, biotech, and academic partners worldwide. The company offers an extensive catalog of screening compounds, including focused libraries, active reference sets, and diverse compound collections, all enhanced by advanced artificial intelligence and machine learning technologies. With a remarkable inventory of 2 million stock compounds and access to 2 trillion synthetically feasible structures, ChemDiv revolutionizes the drug discovery process. Their proprietary libraries span various therapeutic areas and include specialized libraries for cancer, neurological, and infectious diseases, demonstrating their commitment to innovation and scientific advancement. Generated from the website